Languages
Pages
Legal
Explore all categories to find your favorite topic
Dr. Stephan Mumenthaler Head Economic and Swiss Public Affairs Istanbul, November 22, 2012 Innovation through Corporate R&D Leading market position One of 35…
Reimagining Medicine - Strategy UpdateReimagining Medicine Strategy Update Vas Narasimhan, CEO J.P. Morgan Healthcare Conference January 11, 2021 Novartis AG | J.P. Morgan
1. Loretto Callaghan Novartis Ireland MD & Country President Planning for Sustainable Healthcare 2. Novartis is a leader in Healthcare and a major investor in Ireland,…
Novartis AG Media Relations Q4 and Full Year 2016 Results Media presentation | January 25, 2017 Disclaimer This presentation contains forward-looking statements that can…
Drug Pricing Investigation Staff Report Committee on Oversight and Reform U.S. House of Representatives October 2020 oversight.house.gov Novartis—Gleevec Selected Investigation…
Investor Analyst Day November 27 2018 Samir Shah Novartis Global Head Investor Relations Welcome Karen King Alcon Global Head Investor Relations Communications Agenda 3 8:30…
2012 results
VADEMÉCUM 04 Novartis Consumer Health S.A. Gran Via de les Corts Catalanes, 764 08013 Barcelona www.novartismedicalnutrition.com/es N H -1 38 60 -0 4 Módulos y Suplementos…
8/7/2019 MYFORTIC NOVARTIS 1/13MICOFENOLICO CIDOMICOFENOLATO SDICOCON CUBIERTA ENTERICANIDIA A- CALLE REYMERMDICO NEFRLOGAHNLNSPNPMYFORTIC8/7/2019 MYFORTIC NOVARTIS 2/13DROGAS…
8/14/2019 Novartis Analysis 1/258/14/2019 Novartis Analysis 2/258/14/2019 Novartis Analysis 3/258/14/2019 Novartis Analysis 4/258/14/2019 Novartis Analysis 5/258/14/2019…
Galvus Met (vildagliptin, metformin hydrochloride) · ( 2) . 1. 2. 3. 4. (/ ) . 5. (/ ) . · 2 , 100mg 2000mg , . 1 100mg . . 1. : 50/500mg 1 1, 1 1 , 50/1000mg
chain Molecular weight: Approximately 48kDa Structure: Ranibizumab is the Fab moiety of a high affinity version of recombinant humanised monoclonal antibody rhuMAb vascular
-“Re-birth toward life sciences” Table of Contents Contents About Novartis 3 COMPANY PRODUCTS: 3 HISTORY OF NOVARTIS 3 Pattern of actions by Novartis 7 New product development…
Presented by Novartis at the ADB session on "Harnessing and Aligning the Private Sector for Universal Health Coverage" at the Prince Mahidol Award Conference 2016…
8/2/2019 Novartis Foundation 1/15Corporate Philanthropy as anIntegrated ConceptPresented by:Group 1Section B8/2/2019 Novartis Foundation 2/15Corporate Responsibility andCorporate…
R&D ORGANISATIONAL CAPABILITIES OF PRESENTED BY: GUARAV DOSHI TARIKA DUGESHAR PARTH GANDHI HIMANSHU TRIPATHI VINAYAK INDULKAR NOVARTIS INDIA Novartis has been in India…
Final report ANUM ZAHRA 134 SUBMITTED TO SIR ABDUL KHALIQ NOVARTIS CH-4002 BASEL SWITZERLAND 41613241111 41613248001 12/20/2012 1 ABSTRACT Medicine is incredibly important…
1. Novartis & AlconThe takeoverJérémie LORRAIN & Kelly BLASCO 2. IntroductionWhat is a Takeover?Friendly Hostile 3. OverviewPresentation of the companiesReasons…
7/30/2019 Novartis Company PDF 1/14| SEO Presentation | 4 January 20111Our focus is on patientsOur purpose is to care and cure.We provide medicines to treat and prevent diseases,ease…
INNOVATION 1 P H O T O : R O G E R J O B / R E P O R T E R S Building science capacity in Africa Marcelo Gutierrez was born and raised in a developing country. He knows first-hand…